<a href="https://laohu8.com/S/TILE">Interface Inc.</a> Reports Q3 Net Sales Up 5.9% to $364.5 Million
Interface Inc. reported net sales of $364.5 million for the three months ended September 28, 2025, representing a 5.9% increase compared to $344.3 million for the same period in 2024. For the nine months ended September 28, 2025, net sales were $1,037.5 million, up 5.8% from $980.6 million in the prior year period. The company attributed this growth to continued share gains in the Americas and increased momentum in the EAAA region, as well as growth across all regions, product categories, and most market segments. Notably, billings increased by 29% in Healthcare and 5% in Corporate Office. The company also reported that net sales grew on both price and volume, and gross profit margin expanded by 233 basis points, attributed to favorable mix and manufacturing efficiencies. Interface stated that it remains focused on maintaining a strong balance sheet, investing for growth, and margin expansion through disciplined capital allocation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Interface Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251031018061) on October 31, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.